Background Image
Menu

Latest News

New class of coagulant gets go ahead for clinical trial

29 May 2014

New class of coagulant gets go ahead for clinical trial

Haemostatix Ltd announced today that it has received authorisation from the UK regulator, MHRA, to commence a clinical trial of its lead product, PeproStat™. PeproStat is the first of a new class of peptide-based coagulant, or “haemostat”, designed to control...

PolyTherics and Antitope form Abzena

23 May 2014

PolyTherics and Antitope form Abzena

New Company Created to be Leading Provider of Technologies and Services to Enable Better Biopharmaceuticals … • PolyTherics and Antitope to continue to trade as wholly owned subsidiaries of Abzena … • New brand highlights depth and range of offering to the global...

Oxford Cryosystems Wins Export Award category at Made in England Awards 2014

20 May 2014

Oxford Cryosystems Wins Export Award category at Made in England Awards 2014

Catapult portfolio business, Oxford Cryosystems, has been named as the winner of the Export Award category at the 2014 Made in England Awards. The awards, sponsored by Grant Thornton and held in association with South East Midlands Local Enterprise Partnership (SEMLEP)...

Oxford BioTherapeutics Secures Exclusive Global Rights From Amgen and ImmunoG

7 May 2014

Oxford BioTherapeutics Secures Exclusive Global Rights From Amgen and ImmunoG

Oxford BioTherapeutics Takes Exclusive Rights to Use Amgen Xenomouse® Antibodies and ImmunoGen Technology to Develop Novel Antibody-Drug Conjugate for HER2-Negative Breast Cancer … OXFORD, UK and SAN JOSE, CA – 7 May 2014 – Oxford BioTherapeutics, an...

Critical Pharmaceuticals announces US patent allowance

16 April 2014

Critical Pharmaceuticals announces US patent allowance

Critical Pharmaceuticals has announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application directed towards the Company's CP024 Intranasal Growth Hormone and CP046 Intranasal Teriparatide (parathyroid hormone 1-34)...

Monica Healthcare secures N'Tech grant

11 April 2014

Monica Healthcare secures N'Tech grant

A University of Nottingham spin-out has been awarded a grant of more than £250,000 to support a further £1m investment into the business. Monica Healthcare, based at BioCity, is led by Dr Carl Barratt. The company has developed a foetal and maternal monitor, which is...

Oxford Cryosystems helps push the boundaries of the known universe

8 April 2014

Oxford Cryosystems helps push the boundaries of the known universe

Senior management from Oxfordshire-based business Oxford Cryosystems are celebrating their involvement in a global project to create what will eventually become the largest and most sensitive radio telescope on earth. Directors Richard Glazer and Alex Renshaw joined a delegation...

Onwards and upwards for BWB Birmingham

1 April 2014

Onwards and upwards for BWB Birmingham

2013/14 has been a truly remarkable year for BWB’s Birmingham office. Fuelled by successful appointments on a spate of regionally significant projects such as Severn Trent Water’s HQ in Coventry and Resorts World at the NEC, staff numbers in the office is expected to...

Sprue Aegis plc (“Sprue”) and Intamac to launch connected safety solution

27 March 2014

Sprue Aegis plc (“Sprue”) and Intamac to launch connected safety solution

Intamac Systems Limited announces a new 3 year partnership agreement with Sprue, one of Europe’s leading suppliers of home safety products including smoke and carbon monoxide alarms sold under the FireAngel brand. Under the partnership, Sprue will launch an internet...

No Photo

19 March 2014

Biofortuna receives FDA clearance of its SSPGo™ line of HLA molecular diagnostic freeze-dried kits

Biofortuna, a UK based molecular diagnostics company with proprietary freeze drying (lyophilizing) technology, has received FDA 510K clearance for its line of SSPGo™ HLA PCR kits. The SSPGo HLA Typing Kits are qualitative DNA-based kits for determining HLA alleles in low...